We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+39.65%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.91B
AUM Growth
+$647M
Cap. Flow
-$57.9M
Cap. Flow %
-1.99%
Top 10 Hldgs %
34.16%
Holding
142
New
8
Increased
32
Reduced
31
Closed
11

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$68.4M
2
XYL icon
Xylem
XYL
+$29M
3
ROP icon
Roper Technologies
ROP
+$21.6M
4
VMC icon
Vulcan Materials
VMC
+$16.1M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$13.4M

Top Sells

Rank Stock Value
1
SEND
SendGrid, Inc.
SEND
+$77.4M
2
LOXO
Loxo Oncology, Inc
LOXO
+$38.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$36.4M
4
PANW icon
Palo Alto Networks
PANW
+$19.8M
5
SAGE
Sage Therapeutics
SAGE
+$19M

Sector Composition

Rank Sector Weight
1 Healthcare 46.61%
2 Technology 21%
3 Consumer Discretionary 9.25%
4 Industrials 6.6%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.7B
$200M 6.88%
1,698,648
– –
SAGE
2
DELISTED
Sage Therapeutics
SAGE
$128M 4.41%
805,000
-131,000
-14% -$19M
TWLO icon
3
Twilio
TWLO
$29.1B
$107M 3.68%
827,000
+607,000
+276% +$68.4M
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
$104M 3.59%
1,895,000
+182,000
+11% +$8.66M
SRPT icon
5
Sarepta Therapeutics
SRPT
$1.66B
$101M 3.47%
845,168
– –
TTD icon
6
Trade Desk
TTD
$8.13B
$95.2M 3.28%
4,810,000
– –
W icon
7
Wayfair
W
$11.1B
$76.4M 2.63%
514,777
– –
LOW icon
8
Lowe's Companies
LOW
$116B
$61.9M 2.13%
565,000
– –
ROP icon
9
Roper Technologies
ROP
$36.3B
$60.5M 2.08%
177,000
+71,000
+67% +$21.6M
MYOV
10
DELISTED
Myovant Sciences Ltd.
MYOV
$58.9M 2.03%
2,469,021
+264,313
+12% +$5.41M
WCN
11
Waste Connections
WCN
$42.8B
$53.3M 1.84%
602,000
+85,000
+16% +$7.01M
SPLK
12
DELISTED
Splunk Inc
SPLK
$53.3M 1.84%
428,000
-136,000
-24% -$17M
HUBS icon
13
HubSpot
HUBS
$10.5B
$52.7M 1.81%
317,000
-33,000
-9% -$5.23M
PANW icon
14
Palo Alto Networks
PANW
$264B
$51.5M 1.77%
1,272,000
-534,000
-30% -$19.8M
DNTH icon
15
Dianthus Therapeutics
DNTH
$5.68B
$49.7M 1.71%
191,890
+26,214
+16% +$4.52M
BLUE
16
DELISTED
bluebird bio
BLUE
$46.4M 1.6%
22,746
+1,315
+6% +$2.32M
AIMT
17
DELISTED
Aimmune Therapeutics
AIMT
$43.9M 1.51%
1,962,000
+223,000
+13% +$5.25M
FIVN icon
18
FIVE9
FIVN
$1.77B
$42.8M 1.47%
811,000
-83,000
-9% -$4.22M
XPO icon
19
XPO
XPO
$25B
$42.3M 1.46%
2,278,418
– –
LRCX icon
20
Lam Research
LRCX
$382B
$40.6M 1.4%
2,270,000
– –
CCI icon
21
Crown Castle
CCI
$32.7B
$38.4M 1.32%
300,000
– –
LII icon
22
Lennox International
LII
$18.8B
$38.1M 1.31%
144,000
– –
BPMC
23
DELISTED
Blueprint Medicines
BPMC
$37M 1.27%
462,000
+50,000
+12% +$3.69M
ANET icon
24
Arista Networks
ANET
$219B
$36.8M 1.27%
1,872,000
+771,200
+70% +$12.2M
XIFR
25
XPLR Infrastructure LP
XIFR
$1.18B
$36.8M 1.27%
788,500
-2,500
-0.3% -$109K
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Eventide Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Eventide Asset Management held 142 positions worth $2.91B, up 29% from $2.26B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Eventide Asset Management's Q1 2019 filing shows 8 new, 32 increased, 31 reduced and 11 closed positions. Its largest new stake was Xylem: 397,000 shares worth $31.4M. The largest sale was SendGrid, Inc., an estimated $77.4M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q1 2019 buy was Xylem: 397,000 shares worth $31.4M.
  • Eventide Asset Management added most to Twilio in Q1 2019, an estimated $68.4M increase.
  • Eventide Asset Management's biggest Q1 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $36.4M.
  • Eventide Asset Management fully exited SendGrid, Inc. in Q1 2019, selling an estimated $77.4M.
  • Eventide Asset Management's ten largest holdings make up 34% of its $2.91B portfolio in Q1 2019.
  • Eventide Asset Management opened 8 new positions and closed 11 in Q1 2019.
  • Eventide Asset Management's portfolio value rose 29% quarter-over-quarter to $2.91B.

Based on Eventide Asset Management's 13F filing for Q1 2019, filed 15 May 2019.